Dubai Hospital Pioneers Rapid Genetic Sequencing to Transform Care for Critically Ill Children

Al Jalila Children’s Hospital in Dubai has launched a groundbreaking programme known as Little Falcon, utilizing rapid whole-genome sequencing (rWGS) to decode the genetic material of critically ill children in a matter of days. This advanced technology provides faster and more accurate diagnoses for infants and older children admitted to intensive care units, allowing doctors to determine optimal treatments swiftly.

The benefits of rWGS were recently detailed in a study published in the journal Nature Genetics, which examined the procedure in 100 children from 18 Middle Eastern and Asian countries. The majority of the participants were Dubai residents under the age of one. Prof Ahmad Abou Tayoun of Mohammed Bin Rashid University of Medicine and Health Sciences and director of Dubai Health’s Genomic Medicine Centre noted that traditional diagnostic methods relied on sequential testing with lower-yield technologies. This older approach often required weeks or months of trial and error to identify specific abnormalities.

Since its introduction at Al Jalila Children’s Hospital five years ago, rWGS has evolved into the standard diagnostic protocol for children with suspected genetic conditions. Dr Shiva Shankar, a neonatal consultant at the hospital, emphasized that rWGS achieves diagnoses significantly faster, facilitating earlier clinical management, personalized care trajectories, and improved disease outcomes.

The testing regimen is specifically directed at children arriving in neonatal or paediatric intensive care units with unknown illnesses exhibiting single-gene mutation indicators, such as persistent seizures, very low muscle tone, abnormal brain electrical activity, and family histories of genetic disorders. In the study, rWGS successfully delivered a clear diagnosis in 53 per cent of patients, compared to only 30 per cent using conventional approaches.

Driving the wider adoption of rWGS are significant cost reductions. According to Prof Abou Tayoun, average expenses have decreased from approximately $9,200 per patient to a range of $3,500 to $4,500. While historical genetic sequencing efforts like the initial human genome project cost hundreds of millions of dollars, modern operational expenses for rWGS continue to decline. Although deployment requires sophisticated facilities, specialized staff, and accredited frameworks such as the College of American Pathologists—utilized by Al Jalila Children’s Hospital—the heightened diagnostic yield and rapid turnaround justify the early investment.

Prof Abou Tayoun pointed out that rWGS has historically been limited mostly to the US and Europe primarily for research purposes. However, as part of Dubai's first integrated academic health system, Dubai Health is scaling genomic science directly into frontline patient care for critically ill children.